Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma

Surgery (United States)

Volumn 158, Issue 3, 2015, Pages 662-668

  Kachare, Swapnil D ^a   Singla, Patreek ^a   Vohra, Nasreen A ^a   Zervos, Emmanuel E ^a   Wong, Jan H ^a   Fitzgerald, Timothy L ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER REGISTRY; CONFERENCE PAPER; DEMOGRAPHY; DISEASE SPECIFIC SURVIVAL; FEMALE; GENDER; HUMAN; HUMAN TISSUE; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SENTINEL LYMPH NODE BIOPSY; SKIN ULCER; UNIVARIATE ANALYSIS; ADOLESCENT; EVALUATION STUDY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN NEOPLASMS; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938962066     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.05.012     Document Type: Conference Paper

References (38)

1. J.E. Allen, and L.B. Stolle Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma Eur J Surg Oncol 41 2015 197 200
2. S.D. Kachare, J.H. Wong, N.A. Vohra, E.E. Zervos, and T.L. Fitzgerald Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma Ann Surg Oncol 21 2014 1624 1630
3. K.L. Hollowell, S.C. Agle, E.E. Zervos, and T.L. Fitzgerald Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm J Surg Oncol 105 2012 415 419
4. S.D. Kachare, S.C. Agle, Z.P. Englert, E.E. Zervos, N.A. Vohra, J.H. Wong, and et al. Malignant blue nevus: clinicopathologically similar to melanoma Am Surg 79 2013 651 656
5. J.T. Krediet, M. Beyer, K. Lenz, C. Ulrich, B. Lange-Asschenfeldt, E. Stockfleth, and et al. Sentinel lymph node and risk factors for predicting metastasis in cutaneous squamous cell carcinoma Br J Dermatol 172 2015 1029 1036
6. M. Barnes, A. Hestley, D.R. Murray, G.W. Carlson, D. Parker, and K.A. Delman The risk of lymph node involvement in malignant cutaneous adnexal tumors Am Surg 80 2014 270 274
7. I. Stoffels, T. Poeppel, C. Boy, S. Mueller, F. Wichmann, J. Dissemond, and et al. Radio-guided surgery: advantages of a new portable gamma-camera (Sentinella) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies J Eur Acad Dermatol Venereol 26 2012 308 313
8. C.W. Brown Jr., and L.C. Dy Eccrine porocarcinoma Dermatol Ther 21 2008 433 438
9. R.M. Kauffmann, and S.L. Chen Workup and staging of malignant melanoma Surg Clin North Am 94 2014 963 972
10. D.L. Morton, J.F. Thompson, A.J. Cochran, N. Mozzillo, R. Elashoff, R. Essner, and et al. Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317
11. J.E. Gershenwald, W. Thompson, P.F. Mansfield, J.E. Lee, M.I. Colome, C.H. Tseng, and et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 1999 976 983
12. Z.I. Nowecki, P. Rutkowski, A. Nasierowska-Guttmejer, and W. Ruka Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-one institution's experience Melanoma Res 13 2003 35 43
13. S.D. Kachare, J. Brinkley, J.H. Wong, N.A. Vohra, E.E. Zervos, and T.L. Fitzgerald The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma Ann Surg Oncol 21 2014 3377 3385
14. D.L. Morton Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma Clin Exp Metastasis 29 2012 699 706
15. D.L. Morton, J.F. Thompson, A.J. Cochran, N. Mozzillo, O.E. Nieweg, D.F. Roses, and et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma N Engl J Med 370 2014 599 609
16. A.P. van der Ploeg, L.E. Haydu, A.J. Spillane, M.J. Quinn, R.P. Saw, K.F. Shannon, and et al. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution Ann Surg 260 2014 149 157
17. S. Ribero, S. Osella-Abate, M. Sanlorenzo, E. Balagna, R. Senetta, M.T. Fierro, and et al. Sentinel lymph node biopsy in thick-melanoma patients (n=350): what is its prognostic role? Ann Surg Oncol 22 2015 1967 1973
18. A.R. Rhodes Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma: a Bayesian analysis using informative published reports Arch Dermatol 147 2011 408 415
19. N.G. Fairbairn, G. Orfaniotis, and M. Butterworth Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience J Plast Reconstr Aesthet Surg 65 2012 1396 1402
20. I. White, J. Fortino, B. Curti, and J. Vetto Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas Am J Surg 207 2014 702 707
21. T. Hinz, H. Ahmadzadehfar, A. Wierzbicki, T. Hoeller, J. Wenzel, H.J. Biersack, and et al. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution Eur J Nuclear Med Mol Imag 39 2012 1316 1325
22. M.G. Rughani, M.C. Swan, T.S. Adams, A. Marshall, R. Asher, O.C. Cassell, and et al. Sentinel node status predicts survival in thick melanomas: the Oxford perspective Eur J Surg Oncol 38 2012 936 942
23. N. Mozzillo, E. Pennacchioli, S. Gandini, C. Caraco, A. Crispo, G. Botti, and et al. Sentinel node biopsy in thin and thick melanoma Ann Surg Oncol 20 2013 2780 2786
24. T. Gambichler, and L. Scholl Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma J Eur Acad Dermatol Venereol 27 2013 1454 1456
25. Surveillance, Epidemiology, and End Results Program SEER research data (1973-2009) 2011 National Cancer Institute Bethesda, MD
26. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC cancer staging manual 2010 Lippincott Raven Philadelphia
27. Y. Kubo, L.R. Sterling, P.S. Parfrey, K. Gill, K.W. Mahaffey, I. Gioni, and et al. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial Pharm Stat 14 2015 242 251
28. D.G. Coit, J.A. Thompson, R. Andtbacka, C.J. Anker, C.K. Bichakjian, W.E. Carson 3rd, and et al. Melanoma, version 4.2014 J Natl Compr Cancer Netw 12 2014 621 629
29. R. Essner, M.H. Chung, R. Bleicher, E. Hsueh, L. Wanek, and D.L. Morton Prognostic implications of thick (> or = 4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy Ann Surg Oncol 9 2002 754 761
30. J.E. Gershenwald, P.F. Mansfield, J.E. Lee, and M.I. Ross Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma Ann Surg Oncol 7 2000 160 165
31. C.R. Ferrone, K.S. Panageas, K. Busam, M.S. Brady, and D.G. Coit Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status Ann Surg Oncol 9 2002 637 645
32. R. Gutzmer, I. Satzger, K.M. Thoms, B. Volker, C. Mitteldorf, A. Kapp, and et al. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas J Dtsch Dermatol Ges 6 2008 198 203
33. L. Vermeeren, F.W. van der Ent, P.S. Sastrowijoto, and K.W. Hulsewe Thick melanoma: prognostic value of positive sentinel nodes World J Surg 33 2009 2464 2468
34. C. Gajdos, K.A. Griffith, S.L. Wong, T.M. Johnson, A.E. Chang, V.M. Cimmino, and et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 115 2009 5752 5760
35. F. Rondelli, M.C. Vedovati, C. Becattini, G.M. Tomassini, S. Messina, G. Noya, and et al. Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis J Eur Acad Dermatol Venereol 26 2012 560 565
36. E. Minutilli, and C. Feliciani Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors Tumori 98 2012 185 190
37. P.A. Gimotty, F. Yoon, R. Hammond, P. Rosenbaum, and D. Guerry Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question J Clin Oncol 27 2009 4236 4238
38. J. Homsi, M. Kashani-Sabet, J.L. Messina, and A. Daud Cutaneous melanoma: prognostic factors Cancer Control 12 2005 223 229